About ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.
Basic Details
Issuer ProShares
Fund NameProShares UltraShort Nasdaq Biotechnology
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:BIS
Inception Date4/7/2010
Fund ManagerMichael Neches, Devin Sullivan
Phone+1-240-4976400
Fund Focus
Asset ClassEquity
BenchmarkNASDAQ Biotechnology TR USD
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America
Fund Statistics
Assets Under Management$35.12 million
Average Daily Volume$109,729.00
Discount/Premium2.73%
ETF Expenses
Management Fee0.75%
Other Expenses0.36%
Total Expenses1.11%
Fee Waiver-0.16%
Net Expenses0.95%
Administrator, Advisor and Custodian
AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerVirtu Financial
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Frequently Asked Questions
What is ProShares UltraShort Nasdaq Biotechnology's stock symbol?
ProShares UltraShort Nasdaq Biotechnology trades on the NASDAQ under the ticker symbol "BIS."
What price target have analysts set for BIS?
1 analysts have issued 1-year price targets for ProShares UltraShort Nasdaq Biotechnology's shares. Their predictions range from $0.16 to $0.16. On average, they anticipate ProShares UltraShort Nasdaq Biotechnology's share price to reach $0.16 in the next twelve months. View Analyst Ratings for ProShares UltraShort Nasdaq Biotechnology.
Has ProShares UltraShort Nasdaq Biotechnology been receiving favorable news coverage?
News coverage about BIS stock has trended somewhat positive this week, according to Accern Sentiment. The research firm ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. ProShares UltraShort Nasdaq Biotechnology earned a media sentiment score of 0.13 on Accern's scale. They also gave press coverage about the company an impact score of 46.01 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of ProShares UltraShort Nasdaq Biotechnology?
Shares of BIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is ProShares UltraShort Nasdaq Biotechnology's stock price today?
One share of BIS stock can currently be purchased for approximately $21.43.
How big of a company is ProShares UltraShort Nasdaq Biotechnology?
ProShares UltraShort Nasdaq Biotechnology has a market capitalization of $31.22 million.
How can I contact ProShares UltraShort Nasdaq Biotechnology?
ProShares UltraShort Nasdaq Biotechnology's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, Bethesda, MD 20814, United States. The company can be reached via phone at +1-240-4976400.
MarketBeat Community Rating for ProShares UltraShort Nasdaq Biotechnology (BIS)
MarketBeat's community ratings are surveys of what our community members think about ProShares UltraShort Nasdaq Biotechnology and other stocks. Vote "Outperform" if you believe BIS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BIS will underperform the S&P 500 over the long term. You may vote once every thirty days.
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for ProShares UltraShort Nasdaq Biotechnology in the last 12 months. Their average twelve-month price target is $0.16, suggesting that the stock has a possible downside of 99.25%. The high price target for BIS is $0.16 and the low price target for BIS is $0.16. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $0.16 | $0.16 | $0.16 | $0.16 |
| Price Target Upside: | 99.25% downside | N/A | N/A | N/A |
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Consensus Price Target History
Show:
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
ProShares UltraShort Nasdaq Biotechnology (NASDAQ BIS) News Headlines
| Source: |
|
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
ProShares UltraShort Nasdaq Biotechnology (NASDAQ BIS) Stock Chart for Thursday, April, 26, 2018
Loading chart…
